Healthcare -
Biotechnology - NASDAQ - US
$ 0.188
2.68 %
$ 12.3 M
Market Cap
-0.13
P/E
LYRA - LONG-TERM DEBT
Long-term Debt LYRA - Lyra Therapeutics, Inc.
21.4 M
LAST VALUE
652.25%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR